myelofibrosis
Showing NaN - NaN of 17
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)
Recruiting
- Myeloproliferative Disorders
- +4 more
- ACE-536
- Placebo
-
La Jolla, California
- +184 more
Aug 22, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +12 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +2 more
Feb 17, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Withdrawn
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +11 more
- Multi-antigen CMV-Modified Vaccinia Ankara Vaccine
- +2 more
-
Duarte, California
- +2 more
Nov 19, 2018
Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Boston (Haploidentical Bone
Unknown status
- Chronic Kidney Disease
- +16 more
- Haploidentical Bone Marrow/Kidney
-
Boston, MassachusettsMassachusetts General Hospital
Mar 21, 2017
Myelofibrosis, Myeloid Metaplasia, Agnogenic Myeloid Metaplasia Trial in Boston (Imatinib mesylate)
Completed
- Myelofibrosis
- +3 more
- Imatinib mesylate
-
Boston, Massachusetts
- +1 more
Dec 22, 2016
Myelofibrosis Trial in United States (SAR302503 (TG101348))
Completed
- Myelofibrosis
- SAR302503 (TG101348)
-
La Jolla, California
- +5 more
Feb 17, 2016
Leukemia, Myeloid, Chronic, Anemia, Aplastic, Myelofibrosis Trial in Gainesville, Boston (Parathyroid Hormone (teriparatide))
Terminated
- Leukemia, Myeloid, Chronic
- +7 more
- Parathyroid Hormone (teriparatide)
-
Gainesville, Florida
- +3 more
Apr 22, 2013